Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeppe Zacho

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
European Heart Journal|April 29, 2010
C-reactive protein and all-cause mortality--the Copenhagen City Heart StudyJeppe Zacho, Anne Tybjaerg-Hansen, Børge G Nordestgaard
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2010
C-reactive protein and risk of venous thromboembolism in the general populationJeppe Zacho, Anne Tybjaerg-Hansen, Børge G Nordestgaard
Scandinavian Journal of Clinical and Laboratory Investigation|June 18, 2009
C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular diseaseJeppe Zacho, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard
Clinical Chemistry|January 2, 2016
Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population CohortsJeppe Zacho, Thomas Benfield, Anne Tybjærg-Hansen, et al.
Journal of Diabetes Investigation|August 26, 2016
Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trialYukiko Onishi, Kenichi Yamada, Jeppe Zacho, et al.
Advances in Therapy|March 15, 2018
A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian SubjectsIppei Ikushima, Lene Jensen, Anne Flint, et al.
International Journal of Cancer|May 18, 2010
Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controlsJeppe Zacho, Shiva Yazdanyar, Stig E Bojesen, et al.
Thorax|November 10, 2010
C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approachMorten Dahl, Jørgen Vestbo, Jeppe Zacho, et al.
Diabetes, Obesity & Metabolism|January 12, 2018
Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trialKohei Kaku, Yuichiro Yamada, Hirotaka Watada, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 17, 2018
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic AnalysisKristin Cecilie Carlsson Petri, Steen Hvass Ingwersen, Anne Flint, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
European Heart Journal|April 29, 2010
C-reactive protein and all-cause mortality--the Copenhagen City Heart StudyJeppe Zacho, Anne Tybjaerg-Hansen, Børge G Nordestgaard
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2010
C-reactive protein and risk of venous thromboembolism in the general populationJeppe Zacho, Anne Tybjaerg-Hansen, Børge G Nordestgaard
Scandinavian Journal of Clinical and Laboratory Investigation|June 18, 2009
C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular diseaseJeppe Zacho, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard
Clinical Chemistry|January 2, 2016
Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population CohortsJeppe Zacho, Thomas Benfield, Anne Tybjærg-Hansen, et al.
Journal of Diabetes Investigation|August 26, 2016
Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trialYukiko Onishi, Kenichi Yamada, Jeppe Zacho, et al.
Advances in Therapy|March 15, 2018
A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian SubjectsIppei Ikushima, Lene Jensen, Anne Flint, et al.
International Journal of Cancer|May 18, 2010
Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controlsJeppe Zacho, Shiva Yazdanyar, Stig E Bojesen, et al.
Thorax|November 10, 2010
C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approachMorten Dahl, Jørgen Vestbo, Jeppe Zacho, et al.
Diabetes, Obesity & Metabolism|January 12, 2018
Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trialKohei Kaku, Yuichiro Yamada, Hirotaka Watada, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 17, 2018
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic AnalysisKristin Cecilie Carlsson Petri, Steen Hvass Ingwersen, Anne Flint, et al.
Pageof 3